NEW YORK--(BUSINESS WIRE)--Callisto Pharmaceuticals, Inc. (AMEX: KAL; FWB: CA4), a developer of new drug treatments in the fight against cancer and gastrointestinal diseases, announced today that Dr. Kunwar Shailubhai, Sr. VP Discovery Research, will give an oral presentation covering preclinical data on Guanilib at the Crohn’s and Colitis Foundation National Research and Clinical Conference - 6th Annual Advances in the Inflammatory Bowel Diseases during Dec. 6-9, 2007 in Aventura, Florida. Dr. Shailubhai’s presentation is scheduled for 2:00 pm on December 8, 2007.
